173 related articles for article (PubMed ID: 32831922)
1. BRM270 targets cancer stem cells and augments chemo-sensitivity in cancer.
Chandimali N; Koh H; Kim J; Lee J; Park YH; Sun HN; Kwon T
Oncol Lett; 2020 Oct; 20(4):103. PubMed ID: 32831922
[TBL] [Abstract][Full Text] [Related]
2. BRM270 inhibits cancer stem cell maintenance via microRNA regulation in chemoresistant A549 lung adenocarcinoma cells.
Kwon T; Chandimali N; Huynh DL; Zhang JJ; Kim N; Bak Y; Yoon DY; Yu DY; Lee JC; Gera M; Ghosh M; Park YH; Jeong DK
Cell Death Dis; 2018 Feb; 9(2):244. PubMed ID: 29445170
[TBL] [Abstract][Full Text] [Related]
3. The novel inhibitor BRM270 downregulates tumorigenesis by suppression of NF-κB signaling cascade in MDR-induced stem like cancer-initiating cells.
Mongre RK; Sodhi SS; Ghosh M; Kim JH; Kim N; Park YH; Kim SJ; Heo YJ; Sharma N; Jeong DK
Int J Oncol; 2015; 46(6):2573-85. PubMed ID: 25872586
[TBL] [Abstract][Full Text] [Related]
4. BRM270, a Compound from Natural Plant Extracts, Inhibits Glioblastoma Stem Cell Properties and Glioblastoma Recurrence.
Jeon HY; Park CG; Ham SW; Choi SH; Lee SY; Kim JY; Seo S; Jin X; Kim JK; Eun K; Kim EJ; Kim H
J Med Food; 2017 Sep; 20(9):838-845. PubMed ID: 28792781
[TBL] [Abstract][Full Text] [Related]
5. Combined BRM270 and endostatin inhibit relapse of NSCLC while suppressing lung cancer stem cell proliferation induced by endostatin.
Gu YH; Shen YC; Ou-Yang Y; Rao XM; Fu DD; Wen FQ
Mol Ther Oncolytics; 2021 Sep; 22():565-573. PubMed ID: 34553041
[TBL] [Abstract][Full Text] [Related]
6. BRM270 Inhibits the Proliferation of CD44 Positive Pancreatic Ductal Adenocarcinoma Cells via Downregulation of Sonic Hedgehog Signaling.
Huynh DL; Koh H; Chandimali N; Zhang JJ; Kim N; Kang TY; Ghosh M; Gera M; Park YH; Kwon T; Jeong DK
Evid Based Complement Alternat Med; 2019; 2019():8620469. PubMed ID: 31049070
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of the antiproliferative efficacy of BRM270 phytocomposite nanoparticles against human hepatoma cancer cell lines.
Gera M; Kim N; Ghosh M; Sharma N; Huynh DL; Chandimali N; Koh H; Zhang JJ; Kang TY; Park YH; Kwon T; Jeong DK
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():166-176. PubMed ID: 30678901
[TBL] [Abstract][Full Text] [Related]
8. Novel phyto-derivative BRM270 inhibits hepatocellular carcinoma cells proliferation by inducing G2/M phase cell cycle arrest and apoptosis in xenograft mice model.
Kumar Mongre R; Sharma N; Singh Sodhi S; Ghosh M; Kumar Singh A; Kim N; Park YH; Shin YG; Kim SJ; Jiao Jiao Z; Huynh DL; Jeong DK
Biomed Pharmacother; 2017 Mar; 87():741-754. PubMed ID: 28110264
[TBL] [Abstract][Full Text] [Related]
9. Antrodia cinnamomea sensitizes radio-/chemo-therapy of cancer stem-like cells by modulating microRNA expression.
Su YK; Shih PH; Lee WH; Bamodu OA; Wu ATH; Huang CC; Tzeng YM; Hsiao M; Yeh CT; Lin CM
J Ethnopharmacol; 2017 Jul; 207():47-56. PubMed ID: 28602756
[TBL] [Abstract][Full Text] [Related]
10. Trifluoperazine, an antipsychotic agent, inhibits cancer stem cell growth and overcomes drug resistance of lung cancer.
Yeh CT; Wu AT; Chang PM; Chen KY; Yang CN; Yang SC; Ho CC; Chen CC; Kuo YL; Lee PY; Liu YW; Yen CC; Hsiao M; Lu PJ; Lai JM; Wang LS; Wu CH; Chiou JF; Yang PC; Huang CY
Am J Respir Crit Care Med; 2012 Dec; 186(11):1180-8. PubMed ID: 23024022
[TBL] [Abstract][Full Text] [Related]
11. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
Su P; Yang Y; Wang G; Chen X; Ju Y
Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
[TBL] [Abstract][Full Text] [Related]
12. Oct4 plays a crucial role in the maintenance of gefitinib-resistant lung cancer stem cells.
Kobayashi I; Takahashi F; Nurwidya F; Nara T; Hashimoto M; Murakami A; Yagishita S; Tajima K; Hidayat M; Shimada N; Suina K; Yoshioka Y; Sasaki S; Moriyama M; Moriyama H; Takahashi K
Biochem Biophys Res Commun; 2016 Apr; 473(1):125-132. PubMed ID: 26996130
[TBL] [Abstract][Full Text] [Related]
13. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.
Quan YH; Lim JY; Choi BH; Choi Y; Choi YH; Park JH; Kim HK
Cancer Chemother Pharmacol; 2019 Mar; 83(3):399-410. PubMed ID: 30515553
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma.
Mongre RK; Sodhi SS; Sharma N; Ghosh M; Kim JH; Kim N; Park YH; Shin YG; Kim SJ; Jiao ZJ; Huynh do L; Jeong DK
Int J Oncol; 2016 Jan; 48(1):84-98. PubMed ID: 26573874
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer.
Xi C; Wang L; Yu J; Ye H; Cao L; Gong Z
Biochem Biophys Res Commun; 2018 Sep; 503(4):2286-2292. PubMed ID: 29959920
[TBL] [Abstract][Full Text] [Related]
16. Role of FBXW7 in the quiescence of gefitinib-resistant lung cancer stem cells in EGFR-mutant non-small cell lung cancer.
Hidayat M; Mitsuishi Y; Takahashi F; Tajima K; Yae T; Miyahara K; Hayakawa D; Winardi W; Ihara H; Koinuma Y; Wirawan A; Nurwidya F; Kato M; Kobayashi I; Sasaki S; Takamochi K; Hayashi T; Suehara Y; Moriyama M; Moriyama H; Habu S; Takahashi K
Bosn J Basic Med Sci; 2019 Nov; 19(4):355-367. PubMed ID: 31202256
[TBL] [Abstract][Full Text] [Related]
17. Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC.
MacDonagh L; Gallagher MF; Ffrench B; Gasch C; Breen E; Gray SG; Nicholson S; Leonard N; Ryan R; Young V; O'Leary JJ; Cuffe S; Finn SP; O'Byrne KJ; Barr MP
Oncotarget; 2017 Sep; 8(42):72544-72563. PubMed ID: 29069808
[TBL] [Abstract][Full Text] [Related]
18. Understanding the colon cancer stem cells and perspectives on treatment.
Garza-Treviño EN; Said-Fernández SL; Martínez-Rodríguez HG
Cancer Cell Int; 2015; 15(1):2. PubMed ID: 25685060
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells in prostate cancer chemoresistance.
Ni J; Cozzi P; Hao J; Duan W; Graham P; Kearsley J; Li Y
Curr Cancer Drug Targets; 2014; 14(3):225-40. PubMed ID: 24720286
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
Glackin CA
Enzymes; 2018; 44():83-101. PubMed ID: 30360816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
